Ernexa Therapeutics Inc. (ERNA) Other Operating Expenses (2010 - 2026)
Ernexa Therapeutics' (ERNA) quarterly Other Operating Expenses came in at $2.0 million in Q1 2026, up 229.7% on a QoQ basis from -$1.6 million in Q3 2024.
Ernexa Therapeutics Inc. (ERNA) Other Operating Expenses (2010 - 2026) Analysis & Trends
Ernexa Therapeutics (ERNA) has 14 years of Other Operating Expenses data on file, last reported at $2.0 million in Q1 2026.
- Quarterly Other Operating Expenses changed N/A year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 229.7% YoY) and the FY2024 annual result came in at -$1.6 million, down 442.61% from the prior year.
- Other Operating Expenses climbed to $2.0 million in Q1 2026, from -$1.6 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $2.0 million in Q1 2026 to a low of -$1.6 million in Q3 2024.
- A 3-year average of $309333.3 and a median of $460000.0 in 2023 frame the typical range for Other Operating Expenses.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.04 Mn |
| Sep 30, 2024 | -1.58 Mn |
| Jun 30, 2023 | 460,000.00 |
| Jun 30, 2021 | -50,000.00 |
| Mar 31, 2021 | -9.60 Mn |
| Dec 31, 2019 | 3.52 Mn |
| Sep 30, 2019 | 1.48 Mn |
| Jun 30, 2019 | 1.81 Mn |
| Mar 31, 2019 | 1.58 Mn |
| Dec 31, 2018 | 2.41 Mn |
| Sep 30, 2018 | 2.19 Mn |
| Jun 30, 2018 | 2.02 Mn |
| Mar 31, 2018 | 2.05 Mn |
| Dec 31, 2017 | 1.83 Mn |
| Sep 30, 2017 | 1.62 Mn |
| Jun 30, 2017 | 1.72 Mn |
| Mar 31, 2017 | 1.93 Mn |
| Dec 31, 2016 | 2.18 Mn |
| Sep 30, 2016 | 1.85 Mn |
| Jun 30, 2016 | 1.95 Mn |